Boston Scientific director Ernest Mario sold 10,000 shares of company stock at an average of $12.96 per share. The total transaction value was $129,600, according to a WKRB News & Analysis report.
Carnegie Hill Endoscopy in New York will hold an open house to Can gastroenterologists create a sustainable future in uncertain times?FUSE endoscopy technology from EndoChoice.
CMS issued its final payment decision for Exact Sciences’ FDA-approved noninvasive stool DNA colorectal cancer screening test Cologuard. CMS will reimburse providers $502 per test.
The FDA granted the Aer-O-Scope Colonoscope System from GI View 510(k) clearance.
Sanovas, a company focused on the development of minimally invasive diagnostics, has received recognition from Frost & Sullivan for its MicroCam Technology Platform. Sanovas will accept the “New Product Innovation Leadership in Endoscopic Imaging” award on Dec. 2 in Toronto, Canada.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
ASGE, ACG update GI procedure quality indicators
4 gastroenterologists on the move
Can gastroenterologists create a sustainable future in uncertain times?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
